NVO
Novo Nordisk A/S
NVO (Novo Nordisk A/S) has a reliability-weighted signal score of 53/100 on StockMarketSignals, based on 3 finance YouTubers over a rolling 14-day window. The score reflects how strongly tracked creators are currently bullish or bearish on NVO, weighted by each channel's reliability.
Why analysts are watching it
Analysts are watching NVO due to its significant market developments and potential future growth. On June 16, 2026, The Patient Investor highlighted NVO's massive success with its pill launch, noting that the company is "killing Lilly in terms of the oral GLP 1 pill launch" despite losing market share to Lilly in obesity care generally. The Patient Investor also mentioned a massive call option the CEO recently discussed and suggested that "If NVO could do anything with semaglutide to come up with some kind of a drug for aging, protecting organs, or anything, I would expect a massive massive move on the stock." On July 1, 2026, Asymmetric Investing by Travis Hoium observed the company's partnership, stating, "So you've seen their partnership with Novo Nordisk. That is not a coincidence." Couch Investor also listed Novo Nordisk as a stock he bought on August 2, 2026, and as one of "4 Stocks You'll Wish You Bought on This Dip" on June 9, 2026. However, The Patient Investor pointed out on June 16, 2026, that NVO has reduced its injectable Wegovy prices in the United States from $1,200-$1,500 to around $300. Regulatory and market competition risks could impact future performance.
Contributing creators
Source clips
"Before the open, Eli Lilly, Shopify, Uber, Walt Disney, Unity as well, Novo Nordisk for those interested, all before the open."
— I Just Bought $5,200 of These 3 Stocks. Here's Why
"So you've seen their partnership with Novo Nordisk. That is not a coincidence."
— Hims & Hers Stock: Why This Is a 10x Stock
"you had a massive, massive success in the launch of the NVO pill."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"my opinion on NVO. Looks pretty good to me as a risk to reward bet."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"If NVO could do anything with semaglutide to come up with some kind of a drug for aging, protecting organs, or anything, I would expect a massive massive move on the stock."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"NVO is killing Lilly in terms of the oral GLP 1 pill launch."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"So, in the United States, NVO was charging 1,200, 1,300, 1,500 dollars for those injectable Wegovys. Now, they took it down to like 300."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"Now, to be fair, NVO has been losing massive market share to Lilly in obesity care."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"There's a massive call option on NVO, which I haven't talked about before and I didn't even know it existed. But the CEO talked about it recently. It's very very interesting to me."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"Many of you have asked me for an update on NVO stock."
— Novo Nordisk Stock Is Nearing An Inflection Point!
Frequently asked about NVO
Is NVO a buy according to finance YouTubers?
Tracked finance YouTubers are currently mildly bullish / mixed on NVO (Novo Nordisk A/S), giving it a reliability-weighted signal score of 53/100 on StockMarketSignals. This reflects creator sentiment over a rolling 14-day window and is not investment advice.
What is NVO's reliability score?
NVO has a StockMarketSignals reliability score of 53/100, based on 3 finance YouTubers. Scores above 60 indicate net-bullish creator sentiment, while scores below 40 indicate net-bearish sentiment.
Which finance YouTubers cover NVO?
NVO has been covered by Couch Investor, Asymmetric Investing by Travis Hoium, The Patient Investor on StockMarketSignals. Each creator is weighted by a reliability score based on the historical accuracy of their past calls.
How is the NVO signal calculated?
The NVO signal aggregates every tracked YouTuber mention, weighting each by the creator's reliability and decaying older mentions over a 90-day window. Bullish mentions push the score above 50, bearish mentions below it.